Does reduced eGFR increase internal exposure to environmental toxicants?

The relationship between kidney function and the accumulation of environmental toxins is well-established, particularly concerning how a decline in estimated glomerular filtration rate (eGFR) alters the pharmacokinetics of various xenobiotics. For individuals with reduced renal function, the body's ability to clear foreign compounds is compromised, leading to higher internal concentrations even at standard levels of environmental exposure.

Clinical and effectiveness evidence

Large-scale epidemiological studies, including data from the US NHANES and Korean cohorts, consistently demonstrate a negative correlation between eGFR and serum levels of persistent organic pollutants.

• PFAS Accumulation: Research shows that as eGFR declines, the serum concentrations of per- and polyfluoroalkyl substances (PFAS), such as PFOA and PFOS, significantly increase. This is due to the prolonged elimination half-lives of these compounds when filtration capacity is impaired.
• Heavy Metals: Studies in cadmium-polluted regions show that individuals with lower renal clearance exhibit higher internal body burdens of metals like lead and cadmium. High environmental exposure coupled with impaired renal clearance creates a compounding effect, leading to significantly elevated internal exposure levels compared to individuals with preserved kidney function.

Mechanistic explanations

The kidneys facilitate xenobiotic elimination through two primary pathways that are both hindered as eGFR drops:

• Glomerular Filtration: This is the primary route for many low-molecular-weight xenobiotics. A reduction in the available filtration surface area directly decreases the rate at which these toxins are moved from the blood into the primary urine.
• Tubular Transport: Many toxins, including heavy metals and certain pesticides, rely on active transport proteins in the proximal tubules. In the context of reduced eGFR, there is often a concomitant decline in the density or activity of these transporters. For example, the fractional tubular degradation of markers like $\beta_2$-microglobulin decreases alongside eGFR, indicating a broad reduction in the tubular processing of environmental toxicants.
• Toxicant-Excretion Influx Balance: Internal exposure is determined by the balance of influx (environmental burden) and efflux (renal and biliary excretion). When the renal efflux is slowed by low eGFR, the "internal dose" increases because the rate of environmental intake outpaces the body’s diminished elimination capacity.

Bottom line

Reduced eGFR directly slows the renal excretion of xenobiotics and their metabolites by impairing both glomerular filtration and active tubular transport. This results in an increased internal body burden, a risk that is significantly magnified when environmental toxicant exposure is high.